Taking a Look at the Data Behind Agilent Technologies, Inc. (A)

Agilent Technologies, Inc. (A) is an interesting player in the Healthcare space, with a focus on Medical Laboratories & Research. The stock has been active on the tape, currently trading at $68.17, up from yesterday’s close by 1.43%. Given the stock’s recent action, it seemed like a good time to take a closer look at the company’s recent data.

Fundamental Analysis

Agilent Technologies, Inc. (A) currently trades with a market capitalization of $21.98 Billion. That value represents a market adjusting for revenues that have been growing by 13.50 % on a quarterly year/year basis as of the company’s last quarterly report.

You can get a sense of how sustainable that is by a levered free cash flow of $784 Million over the past twelve months. Generally speaking, earnings are expected to grow in coming quarters. Analysts are forecasting earnings of $0.64 on a per share basis this quarter. Perhaps, that suggests something about why 1.15% of the outstanding share supply is held by institutional investors.



Technical Analysis

As most professionals know, technical analysis can offer critical insights into what smart money and insiders think about a stock’s prospects going forward. Looking at the stock’s movement on the chart, Agilent Technologies, Inc. recorded a 52-week high of $75.00. It is now trading 6.83% off that level. The stock is trading $68.37 its 50-day moving average by 0.2%. The stock carved out a 52-week low down at $52.43.

In recent action, Agilent Technologies, Inc. (A) has made a move of -2.47% over the past month, which has come on Strong relative transaction volume. Over the trailing year, the stock is underperforming the S&P 500 by 13.41, and it’s gotten there by action that has been more volatile on a day-to-day basis than most other stocks on the exchange. In terms of the mechanics underlying that movement, traders will want to note that the stock is trading on a float of 1.17% with $321.63 Million sitting short, betting on future declines. That suggests something of the likelihood of a short squeeze in shares of A.

SHARE
Previous articleJust the Facts on Archer-Daniels-Midland Company (ADM)
Next articleDigging Up the Facts on Brandywine Realty Trust (BDN)